The startups we track
Venture-backed UK startups at Series A and beyond, with their funding and how many roles they have open today.
196 companies
| Company | Sector | Latest round | HQ | Open roles |
|---|---|---|---|---|
 Nscale AI infrastructure / cloud. Sponsors visas | AI & Enterprise Software | Series C $2bn, 2026-03 | London | 282 |
 Wayve Autonomous driving / embodied AI. Sponsors visas | Deeptech | Series D+ $1.5bn, 2026-02 | London | 195 |
 Humanoid Humanoid robotics. Sponsors visas | Deeptech | Series A $152m, 2026-07 | London | 96 |
Fuse Energy Energy supply & renewable generation. Sponsors visas | Climate & Energy | Series B $30m, 2026-06 | London | 74 |
 Omnea Procurement SaaS. Sponsors visas | AI & Enterprise Software | Series B $50m, 2025-09 | London | 72 |
 Monzo Banking (neobank). Sponsors visas | Fintech | Growth Secondary at $5.9bn valuation, 2024-10 | London | 63 |
 Luminance Legaltech / AI. Sponsors visas | AI & Enterprise Software | Series C $75m, 2025-02 | London | 52 |
 Sokin Cross-border payments | Fintech | Series B $50M, 2025-12 | London | 52 |
 Zen Educate Teacher staffing marketplace. Sponsors visas | Edtech | Series B $37m, 2024-05 | London | 52 |
 Butternut Box D2C fresh dog food subscription | Consumer & Marketplaces | Series D+ £275m | London | 48 |
 Open Cosmos Space / satellites. Sponsors visas | Deeptech | Growth €300m, 2026-09 | Didcot (Harwell) | 47 |
 PhysicsX AI for engineering. Sponsors visas | AI & Enterprise Software | Series C $300m, 2026-06 | London | 41 |
 Metaview HR tech / AI recruiting. Sponsors visas | AI & Enterprise Software | Series B $35m, 2025-06 | London | 39 |
 Quantexa Fincrime / decision intelligence. Sponsors visas | Fintech | Series D+ $175m, 2025-03 | London | 39 |
 Riverlane Quantum error correction. Sponsors visas | Deeptech | Series C $75m, 2024-08 | Cambridge | 39 |
 incident.io Developer tools / incident management | AI & Enterprise Software | Series B $62m, 2025-04 | London | 37 |
 Universal Quantum Quantum computing (trapped-ion) | Deeptech | Series A $100M, 2026-10 | Haywards Heath | 36 |
 9fin B2B finance software (credit market intelligence). Sponsors visas | Fintech | Series C $170m | London | 35 |
 Dexory Warehouse robotics. Sponsors visas | Deeptech | Series C $165m, 2025-10 | London | 35 |
 Encord AI data infrastructure. Sponsors visas | AI & Enterprise Software | Series C $60m, 2026-02 | London | 35 |
 inforcer Microsoft 365 security for MSPs. Sponsors visas | Cybersecurity | Series C $50m, 2026-07 | London | 34 |
 Flo Health Femtech / women's health app. Sponsors visas | Health & Life Sciences | Series C $200m, 2024-07 | London | 33 |
 Nivoda B2B diamond & gemstone marketplace | Consumer & Marketplaces | Series B ~$52.7m (€48.4m), 2024-11 | London | 32 |
 Oxford Quantum Circuits (OQC) Quantum computing hardware. Sponsors visas | Deeptech | Series C £260m, 2026-06 | Reading | 32 |
 Synthesia Generative AI video. Sponsors visas | AI & Enterprise Software | Series D+ $200m, 2026-01 | London | 32 |
 Multiverse Workforce upskilling / apprenticeships. Sponsors visas | Edtech | Growth $70m, 2026-05 | London | 29 |
 Outpost Cross-border payments & tax compliance | Fintech | Series A $17.5M (£13M), 2026-03 | London | 29 |
 Dwelly AI lettings / property management roll-up | Proptech | Series A €36.8m equity (+€42.6m debt), 2026-02 | London | 28 |
 Primer Payments infrastructure (orchestration). Sponsors visas | Fintech | Series C $100m, 2026-05 | London | 27 |
 Allica Bank Banking (SME bank). Sponsors visas | Fintech | Series D+ $155m, 2026-02 | London | 25 |
 Conduct Enterprise IT / legacy code AI. Sponsors visas | AI & Enterprise Software | Series A £44.7m, 2026-06 | London | 25 |
 Elliptic Crypto compliance / blockchain analytics. Sponsors visas | Fintech | Series D+ $120m (~£89m), 2026-05 | London | 25 |
 Fractile AI inference chips / semiconductors. Sponsors visas | Deeptech | Series C £577m, 2026-10 | London | 25 |
 Wordsmith AI Legaltech / AI. Sponsors visas | AI & Enterprise Software | Series A $25m, 2025-06 | Edinburgh | 24 |
CuspAI AI for materials discovery. Sponsors visas | AI & Enterprise Software | Series A $100m, 2025-09 | Cambridge | 22 |
 Granola AI productivity / meeting notes. Sponsors visas | AI & Enterprise Software | Series C $125m, 2026-03 | London | 22 |
 Nevis Wealth / wealthtech software. Sponsors visas | Fintech | Series B $70m, 2026-10 | London | 21 |
 OLIX AI inference semiconductors. Sponsors visas | Deeptech | Series B $312m (£231.8m), 2026-08 | London | 21 |
 Quantum Motion Quantum computing (silicon). Sponsors visas | Deeptech | Series C £117.5m, 2026-05 | London | 20 |
 HIVED Electric last-mile parcel delivery. Sponsors visas | Logistics & Mobility | Series B $42m, 2025-07 | London | 19 |
 Midnite Online sportsbook / betting | Consumer & Marketplaces | Series C $35M (£26.1M), 2026-01 | London | 19 |
 tem Energy trading / transaction infrastructure. Sponsors visas | Climate & Energy | Series B $75m, 2026-02 | London | 19 |
 Hometree Home services, cover & green energy financing. Sponsors visas | Proptech | Series B $46m, 2023-04 | London | 18 |
 Scarlet AI medical device certification (notified body) | Health & Life Sciences | Series B $50M, 2026-10 | London | 18 |
 Greenjets Aerospace propulsion / defence drones. Sponsors visas | Deeptech | Series A $40m (£30m), 2026-07 | Milton Keynes | 17 |
 Motorway Used-car selling marketplace. Sponsors visas | Consumer & Marketplaces | Series C $190m, 2021-11 | London | 17 |
 Orbital Legaltech / property AI. Sponsors visas | AI & Enterprise Software | Series B $60m, 2026-01 | London | 17 |
 Axle Energy Grid flexibility / DER aggregation. Sponsors visas | Climate & Energy | Series A $25m, 2026-07 | London | 16 |
 Numan Digital health / men's and weight health. Sponsors visas | Health & Life Sciences | Series B $60m ($30m equity + growth capital), 2025-07 | London | 16 |
 Runware AI inference infrastructure / media generation API. Sponsors visas | AI & Enterprise Software | Series A $50M, 2025-12 | London | 15 |
 Basecamp Research AI drug discovery / techbio. Sponsors visas | Health & Life Sciences | Series C $140m, 2026-09 | London | 14 |
Marshmallow Insurtech (car insurance). Sponsors visas | Fintech | Series C $90m, 2025-04 | London | 13 |
 Accurx Primary care communication software. Sponsors visas | Health & Life Sciences | Series B $38m (£27.5m), 2021-09 | London | 12 |
 Ankar AI for patents / IP. Sponsors visas | AI & Enterprise Software | Series A $20M (£15M), 2025-12 | London | 12 |
 Sona Workforce management | AI & Enterprise Software | Series B £34m (~$45m), 2026-04 | London | 12 |
 ThreatAware Cyber asset management. Sponsors visas | Cybersecurity | Series A $25M (£18.5M), 2026-02 | London | 12 |
 Valarian Sovereign infrastructure / defence software. Sponsors visas | AI & Enterprise Software | Series A $50m (£37.3m), 2026-07 | London | 12 |
 Flagright Financial crime compliance / AML | Fintech | Series A £9.3m, 2026-06 | London | 11 |
Harmonic Security AI usage governance and data protection | Cybersecurity | Series B $50M, 2026-10 | London | 11 |
 Phasecraft Quantum algorithms / software. Sponsors visas | Deeptech | Series B $34m, 2025-09 | London | 11 |
 Stream Workplace finance / earned wage access. Sponsors visas | Fintech | Series D+ $90M (£67M), 2026-01 | London | 11 |
 Artificial Labs Insurtech (specialty insurance). Sponsors visas | Fintech | Series B $45M (£33M), 2026-02 | London | 10 |
 Cloudsmith DevOps / software supply chain. Sponsors visas | AI & Enterprise Software | Series C £53m, 2026-04 | Belfast | 10 |
 CoMind Neurotechnology / medtech. Sponsors visas | Health & Life Sciences | Series A $60M (£45M), 2025-10 | London | 10 |
 NewOrbit Space Space / VLEO satellites. Sponsors visas | Deeptech | Series A £13.9m, 2026-06 | Reading | 10 |
 Semble Healthcare practice management software | Health & Life Sciences | Series C £30m, 2026-06 | London | 10 |
Velocity Stablecoin treasury & payments | Fintech | Series A $38m, 2026-07 | London | 10 |
 Jack & Jill AI recruiting agents | AI & Enterprise Software | Series A $40m (£30m), 2026-09 | London | 9 |
 Cellular Origins Cell therapy manufacturing automation | Health & Life Sciences | Series A €34.2M, 2025-12 | Cambridge | 8 |
Fyxer AI AI productivity. Sponsors visas | AI & Enterprise Software | Series B $30m, 2025-09 | London | 8 |
 Modo Energy Energy storage analytics / market data. Sponsors visas | Climate & Energy | Series B $30m, 2025-12 | London | 8 |
 Nothing Consumer electronics (smartphones, audio). Sponsors visas | Consumer & Marketplaces | Series C ~€172m (~$200m), 2025-09 | London | 8 |
 Nu Quantum Quantum networking / photonics. Sponsors visas | Deeptech | Series A $60m, 2025-12 | Cambridge | 8 |
 Sequence Billing / revenue automation. Sponsors visas | Fintech | Series A $20M (£15M), 2025-12 | London | 8 |
 Shellworks Biodegradable packaging materials. Sponsors visas | Climate & Energy | Series A $15M (£11.25M), 2026-03 | London | 8 |
 Yonder Consumer credit (rewards credit card). Sponsors visas | Fintech | Series B £23.4m, 2024-09 | London | 8 |
 Capsa AI B2B finance software (private capital AI). Sponsors visas | Fintech | Series A $18m, 2026-06 | London | 7 |
 Doccla Virtual wards / remote monitoring. Sponsors visas | Health & Life Sciences | Series B £35m ($46m), 2024-09 | London | 7 |
 Geordie AI AI agent security. Sponsors visas | Cybersecurity | Series A £22.3m, 2026-05 | London | 7 |
 Gigaton Industrial decarbonisation software. Sponsors visas | Climate & Energy | Series A £19.3m, 2026-06 | London | 7 |
 Gradient Labs B2B finance software (AI customer ops for financial services). Sponsors visas | Fintech | Series A $13m (extension; Series A total $26m), 2026-06 | London | 7 |
 KatKin D2C fresh cat food. Sponsors visas | Consumer & Marketplaces | Series C $50M (equity + debt), 2025-12 | London | 7 |
 Latent Labs AI protein design / techbio. Sponsors visas | Health & Life Sciences | Series A $40m, 2025-02 | London | 7 |
 Lawhive Legaltech / AI law firm. Sponsors visas | AI & Enterprise Software | Series B $60m, 2026-02 | London | 7 |
 Limbic Mental health AI. Sponsors visas | Health & Life Sciences | Series A $14m, 2024-03 | London | 7 |
 MAGIC AI Connected fitness | Consumer & Marketplaces | Series B £8m, 2026-09 | London | 7 |
 Orbital Industries AI materials / data centre hardware | Deeptech | Series B £37m ($50m), 2026-05 | London | 7 |
 Tessl AI devtools. Sponsors visas | AI & Enterprise Software | Series A $100m, 2024-11 | London | 7 |
 Carmoola Consumer lending (car finance). Sponsors visas | Fintech | Series A £15.5m, 2024-01 | London | 6 |
 Cytix Application security / change risk. Sponsors visas | Cybersecurity | Series A €6m, 2026-08 | Manchester | 6 |
 iGii Advanced materials / carbon nanomaterial. Sponsors visas | Deeptech | Series B £22.7m (€26.5m), 2026-09 | Stirling | 6 |
 Isometric Carbon removal / climate verification. Sponsors visas | Climate & Energy | Series A $50m, 2026-09 | London | 6 |
 Salience Labs Photonic networking chips for AI data centres | Deeptech | Series B $125M, 2026-10 | Oxford | 6 |
 Scope AI AI for testing, inspection & certification | AI & Enterprise Software | Series A $20m (£14.9m), 2026-05 | London | 6 |
 Simple Digital health / weight and fasting app. Sponsors visas | Health & Life Sciences | Series A £26M, 2025-10 | London | 6 |
Trigger.dev Developer tools | AI & Enterprise Software | Series A $16m, 2025-12 | London | 6 |
 Automata Lab automation / AI-ready labs. Sponsors visas | Health & Life Sciences | Series C $45m, 2026-01 | London | 5 |
 Ben HR tech / employee benefits | AI & Enterprise Software | Series B £20.8M ($27.5M), 2025-12 | London | 5 |
Fleek B2B secondhand fashion marketplace. Sponsors visas | Consumer & Marketplaces | Series B $25m (£18.7m), 2026-07 | London | 5 |
 Griffin Banking-as-a-service / embedded finance. Sponsors visas | Fintech | Series A $24m, 2024-03 | London | 5 |
Lottie Later-living / care home marketplace. Sponsors visas | Consumer & Marketplaces | Series A $21m, 2023-10 | London | 5 |
 Qureight AI medical imaging for clinical trials | Health & Life Sciences | Series B £15m ($20m), 2026-07 | Cambridge | 5 |
 Risk Ledger Supply chain security. Sponsors visas | Cybersecurity | Series B £24m, 2026-07 | London | 5 |
 StackOne AI integration infrastructure. Sponsors visas | AI & Enterprise Software | Series A $20m, 2025-05 | London | 5 |
 Tokamak Energy Fusion energy / HTS magnets. Sponsors visas | Climate & Energy | Growth $125m, 2024-11 | Abingdon (Milton Park) | 5 |
 Engitix Biotech / extracellular matrix drug discovery. Sponsors visas | Health & Life Sciences | Series A £20M Series A extension, 2026-01 | London | 4 |
 Lindus Health Clinical trials / CRO tech. Sponsors visas | Health & Life Sciences | Series B $55m, 2025-01 | London | 4 |
 Paymentology Payments infrastructure (card issuing/processing). Sponsors visas | Fintech | Growth $175m, 2026-05 | London | 4 |
 Tropic Agrifood biotech / gene-edited crops. Sponsors visas | Climate & Energy | Series C £78.6M, 2026-03 | Norwich | 4 |
 TrueLayer Open banking / pay by bank | Fintech | Growth $27M, 2026-10 | London | 4 |
 Wrisk Insurtech (embedded auto insurance). Sponsors visas | Fintech | Series B Undisclosed, 2026-01 | London | 4 |
 01Health Digital health / specialist care platform | Health & Life Sciences | Series A $15m (£11.2m), 2026-06 | London | 3 |
 FINBOURNE Technology B2B finance software (investment data management). Sponsors visas | Fintech | Series B £55m, 2024-06 | London | 3 |
 Greyparrot AI waste analytics | Climate & Energy | Series B $27m, 2026-07 | London | 3 |
 LemonEdge Private markets fund accounting | Fintech | Series A $21m (£15.8m), 2026-07 | London | 3 |
 SheMed Women's health / GLP-1 weight management. Sponsors visas | Health & Life Sciences | Series A $50M, 2025-10 | London | 3 |
 Skin Analytics AI dermatology / medtech. Sponsors visas | Health & Life Sciences | Series B £15m, 2025-04 | London | 3 |
 SolveAI AI app builder / no-code | AI & Enterprise Software | Series A $45M Series A (+$5M pre-seed; $50M total), 2026-02 | London | 3 |
 Tembo Mortgages / savings (first-time buyers). Sponsors visas | Fintech | Series B £14m, 2024-11 | London | 3 |
 Tracebit Deception / threat detection. Sponsors visas | Cybersecurity | Series A $20m, 2026-03 | London | 3 |
 Trybe Vertical SaaS (spa & leisure) | AI & Enterprise Software | Series A $30M (£22.4M), 2026-01 | London | 3 |
 Atom Learning K-12 / 11+ exam prep. Sponsors visas | Edtech | Series A $25m, 2021-12 | London | 2 |
 Constructive Bio Synthetic biology / biotech. Sponsors visas | Health & Life Sciences | Series A $58m, 2024-09 | Cambridge | 2 |
 Forest Shared e-bike micromobility | Logistics & Mobility | Series B £27m (second close; ~€19m equity + €11m asset finance), 2026-04 | London | 2 |
 Nyobolt Fast-charging batteries. Sponsors visas | Climate & Energy | Series C £44m ($60m), 2026-05 | Cambridge | 2 |
 Tilt Live shopping / auction marketplace. Sponsors visas | Consumer & Marketplaces | Series A €16.1m, 2024-08 | London | 2 |
 Alchemab Therapeutics AI drug discovery / antibodies. Sponsors visas | Health & Life Sciences | Series A £25m (~$34m), 2026-07 | Cambridge | 1 |
 Antiverse AI antibody discovery. Sponsors visas | Health & Life Sciences | Series A $9.3M (£7M), 2026-03 | Cardiff | 1 |
Evaro Embedded digital health / e-prescribing | Health & Life Sciences | Series A $25M (£18.3M), 2026-01 | Norwich | 1 |
 Healx AI drug discovery (rare disease). Sponsors visas | Health & Life Sciences | Series C $47m, 2024-08 | Cambridge | 1 |
 IMU Biosciences Immune profiling diagnostics | Health & Life Sciences | Series A £40m ($53m), 2026-06 | London | 1 |
 Kohort Mobile gaming / user acquisition AI. Sponsors visas | AI & Enterprise Software | Series A $7m (£5.15m), 2026-05 | London | 1 |
 OMass Therapeutics Biotech / small-molecule drug discovery | Health & Life Sciences | Series C $310M (£233.8m), 2026-10 | Oxford | 1 |
 PolyAI Conversational voice AI. Sponsors visas | AI & Enterprise Software | Series D+ $86m, 2025-12 | London | 1 |
 SatVu Space / thermal Earth observation. Sponsors visas | Deeptech | Growth £30M, 2026-02 | London | 1 |
 Theia Insights AI financial data / classification. Sponsors visas | Fintech | Series A $8M (£6M), 2026-03 | Cambridge | 1 |
 44.01 Carbon removal / CO2 mineralisation | Climate & Energy | Series A $37m, 2024-07 | London | 0 |
 Adfin B2B payments / invoicing & credit control. Sponsors visas | Fintech | Series A $18m, 2026-05 | London | not tracked |
adsilico AI simulation of medical devices on virtual patients | Health & Life Sciences | Series A £10m, 2026-10 | Leeds | not tracked |
 Airspeed Agentic go-to-market / RevOps | AI & Enterprise Software | Series A £14.9m, 2026-06 | London | 0 |
 Apoha AI materials / molecular sensing. Sponsors visas | Deeptech | Series A $36m (£26.7m), 2026-06 | London | not tracked |
 Apron B2B payments (SMB bills & payables). Sponsors visas | Fintech | Series B $30m, 2024-09 | London | 0 |
 Arrakis Industrial AI agents. Sponsors visas | AI & Enterprise Software | Series A $30m Series A (plus $7.5m seed; $38m total), 2026-07 | London | not tracked |
 Artios Pharma Biotech / DNA damage response oncology. Sponsors visas | Health & Life Sciences | Series D+ $115M (£87M), 2025-11 | Cambridge | not tracked |
 bit.bio Synthetic biology / cell programming. Sponsors visas | Health & Life Sciences | Series C $50M, 2026-01 | Cambridge | 0 |
 Bound FX risk management. Sponsors visas | Fintech | Series A $24.5M (£17.9M), 2026-02 | London | not tracked |
 Brainomix AI medical imaging. Sponsors visas | Health & Life Sciences | Series C £4.8M Series C extension, 2026-02 | Oxford | 0 |
 Breedr Agritech / livestock data | Other | Series B $27m (€23m), 2026-08 | Bristol | not tracked |
 CellCentric Biotech / oncology | Health & Life Sciences | Series D+ $220m (~£162m), 2026-05 | Cambridge | not tracked |
 Cera Home healthcare / AI care platform. Sponsors visas | Health & Life Sciences | Growth $150m, 2025-01 | London | not tracked |
 Certain Energy Long-duration energy storage | Climate & Energy | Series A £10m, 2026-09 | London | not tracked |
Circuit Mind AI for electronics and circuit board design | Deeptech | Series A £18.8m, 2026-10 | London | not tracked |
 CloudNC AI for CNC machining. Sponsors visas | Deeptech | Series B $20m, 2026-09 | London | not tracked |
 Cocoon Carbon Low-carbon cement materials. Sponsors visas | Climate & Energy | Series A £11M, 2026-03 | London | not tracked |
Concretene Graphene additive for low-carbon concrete | Climate & Energy | Series A £4.5m (first close), 2026-10 | Manchester | not tracked |
 Cytospire Therapeutics Biotech / immuno-oncology. Sponsors visas | Health & Life Sciences | Series A £61m ($83m), 2026-05 | London | not tracked |
 Dogtooth Technologies Agri robotics | Deeptech | Growth £14m, 2026-07 | Cambridge | not tracked |
Easol Commerce platform for experience businesses | AI & Enterprise Software | Series A £22.5m (£15m equity, £7.5m debt), 2026-10 | London | not tracked |
 Edgify Edge AI for retail | AI & Enterprise Software | Series A $9m (Series A+), 2026-08 | London | not tracked |
 Flok Health Digital MSK / AI physiotherapy. Sponsors visas | Health & Life Sciences | Series A $12.5m (~£9.3m), 2026-06 | Cambridge | not tracked |
 Fresha Beauty & wellness booking marketplace. Sponsors visas | Consumer & Marketplaces | Growth $80m, 2026-05 | London | 0 |
 Genie AI Legaltech / AI. Sponsors visas | AI & Enterprise Software | Series A $17.8m, 2024-10 | London | 0 |
Giraffe360 Real estate media / AI photography. Sponsors visas | Proptech | Series B $10M (£7.5M), 2026-03 | London | 0 |
 Holibob Tours & activities distribution tech. Sponsors visas | Travel | Series A $12m, 2022-07 | London | not tracked |
 HydRegen Biocatalytic hydrogenation / green chemistry | Climate & Energy | Series A £6m (first close), 2026-10 | Oxford | not tracked |
 Hypervision Surgical Medtech / surgical imaging. Sponsors visas | Health & Life Sciences | Series A £17m, 2026-04 | London | not tracked |
 i6 Group Aviation fuel management software | Climate & Energy | Series B £15.1M ($20M), 2025-10 | Hampshire | 0 |
 Immaterial Advanced materials (monolithic MOFs) for carbon capture / decarbonisation. Sponsors visas | Climate & Energy | Series A £13.5M (Series A2), 2025-10 | Cambridge | not tracked |
 Isembard Defence & aerospace advanced manufacturing. Sponsors visas | Deeptech | Series A $50m, 2026-03 | London | not tracked |
 Kord Fincrime / regtech (ID, compliance, payments) | Fintech | Series A £6.4m, 2026-07 | London | 0 |
 Kraken Technology Group Defence / uncrewed maritime systems. Sponsors visas | Deeptech | Series B $175m (£130m), 2026-07 | Fareham | not tracked |
Living Optics Hyperspectral imaging cameras | Deeptech | Growth $20M (£15.1m), 2026-10 | Oxford | 0 |
 Meatly Foodtech / cultivated pet food | Consumer & Marketplaces | Series A £10.4m, 2026-05 | London | not tracked |
 Mestag Therapeutics Biotech / immuno-oncology & fibrosis. Sponsors visas | Health & Life Sciences | Growth $40M, 2026-03 | Cambridge | not tracked |
 Microbiotica Microbiome therapeutics | Health & Life Sciences | Series C £36m (first close), 2026-10 | Cambridge | not tracked |
 Mindgard AI security. Sponsors visas | Cybersecurity | Series A $30m, 2026-08 | London | not tracked |
 Moa Technology Agritech / herbicide discovery. Sponsors visas | Climate & Energy | Series C £22.2m, 2026-07 | Oxford | not tracked |
 Mondra Food supply chain carbon / sustainability data. Sponsors visas | Climate & Energy | Series A £10M, 2025-10 | London | not tracked |
Optalysys Photonic computing / encrypted compute. Sponsors visas | Deeptech | Series A £23M Series A extension, 2026-01 | Leeds | not tracked |
 PolyModels Hub AI/modelling software for pharma process development | Health & Life Sciences | Series A £7M, 2025-11 | London | 0 |
pubX Adtech / AI yield optimisation for publishers | AI & Enterprise Software | Series A $5M (Series A+), 2026-10 | London | not tracked |
 Reclinker Low-carbon cement / construction materials | Climate & Energy | Series A £10m, 2026-10 | Cambridge | not tracked |
 Reelables Supply-chain tracking / smart labels. Sponsors visas | Logistics & Mobility | Series A $10.4M (£8.3M), 2025-11 | London | not tracked |
 RQ Bio Biotech / antibodies. Sponsors visas | Health & Life Sciences | Series A £85.5m ($115m), 2026-06 | London | not tracked |
 Saturn Wealthtech / AI for financial advisers | Fintech | Series A $15M (£11M / €12.9M), 2025-10 | London | not tracked |
 Sava Wearable biosensors / glucose monitoring | Health & Life Sciences | Series B €32.1m, 2026-10 | London | not tracked |
Sensible Biotechnologies mRNA manufacturing in cells | Health & Life Sciences | Series A $47M (incl. up to $20m non-dilutive), 2026-10 | Oxford | not tracked |
 Sidekick Wealth / investing | Fintech | Series A £7.8m, 2026-02 | London | 0 |
 Sitehop Quantum-safe hardware encryption. Sponsors visas | Cybersecurity | Series A £7.5M, 2025-10 | Sheffield | not tracked |
 Space Forge In-space manufacturing. Sponsors visas | Deeptech | Series A £22.6m, 2025-05 | Cardiff | 0 |
 StirlingX Defence drones / data intelligence | Deeptech | Series A £15.1m ($20m), 2026-07 | Milton Keynes | not tracked |
 SurrealDB Databases / AI infrastructure. Sponsors visas | AI & Enterprise Software | Series A $23M (£17M) Series A extension, 2026-02 | London | 0 |
 T-Therapeutics Biotech / TCR bispecific immunotherapies. Sponsors visas | Health & Life Sciences | Series A £24M extension (Series A total $91M), 2025-11 | Cambridge | not tracked |
 TidalSense Respiratory diagnostics. Sponsors visas | Health & Life Sciences | Series B £14.2m ($19m), 2026-07 | Cambridge | 0 |
Vyntelligence Agentic video AI for field operations | AI & Enterprise Software | Series B £23M ($30M), 2025-11 | London | 0 |
 Whitespace Sovereign AI platform | AI & Enterprise Software | Series A £10M, 2025-11 | Belfast | not tracked |